These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 15858865

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Jefferys RJ.
    Neurology; 2005 Aug 23; 65(4):657-8; author reply 657-8. PubMed ID: 16116145
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Sherry JH, Bechtel T.
    Neurology; 2005 Aug 23; 65(4):657-8; author reply 657-8. PubMed ID: 16118859
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Lower phenytoin serum levels in persons switched from brand to generic phenytoin.
    Burkhardt RT, Leppik IE, Blesi K, Scott S, Gapany SR, Cloyd JC.
    Neurology; 2004 Oct 26; 63(8):1494-6. PubMed ID: 15505173
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Clinical outcomes associated with brand-to-generic phenytoin interchange.
    Kinikar SA, Delate T, Menaker-Wiener CM, Bentley WH.
    Ann Pharmacother; 2012 May 26; 46(5):650-8. PubMed ID: 22550275
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The clinical and economic impact of generic drugs in the treatment of epilepsy].
    Argumosa A, Herranz JL.
    Rev Neurol; 2012 May 26; 41(1):45-9. PubMed ID: 15999330
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Debate: Substitution of generic drugs in epilepsy: is there cause for concern?
    Gidal BE, Tomson T.
    Epilepsia; 2008 Dec 26; 49 Suppl 9():56-62. PubMed ID: 19087118
    [Abstract] [Full Text] [Related]

  • 20. Generic substitution in the treatment of epilepsy: patient and physician perceptions.
    Berg MJ, Gross RA, Haskins LS, Zingaro WM, Tomaszewski KJ.
    Epilepsy Behav; 2008 Nov 26; 13(4):693-9. PubMed ID: 18589000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.